Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease

References

• Smith BW, Adams LA. Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci 2011;48:97–113.
   PubMed Web of Science ®Google Scholar
• Day CP. Non-alcoholic fatty liver disease: a massive problem. Clin Med 2011;11:176–8.
   PubMed Web of Science ®Google Scholar
• Brunt EM. Non-alcoholic fatty liver disease: what's new under the microscope? Gut 2011;60:1152–8.
   PubMed Web of Science ®Google Scholar
• Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch 2011;458:511–23.
   PubMed Web of Science ®Google Scholar
• Moore JB. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc Nutr Soc 2010;69:211–20.
   PubMed Web of Science ®Google Scholar
• Palasciano G, Moschetta A, Palmieri VO, Grattagliano I, Iacobellis G, Portincasa P. Non-alcoholic fatty liver disease in the metabolic syndrome. Curr Pharm Des 2007;13:2193–8.
   PubMedGoogle Scholar
• Yilmaz Y, Ulukaya E. Toward a biochemical diagnosis of NASH: insights from pathophysiology for distinguishing simple steatosis from steatohepatitis. Curr Med Chem 2011;18:725–32.
   PubMedGoogle Scholar
• Myers RP. Noninvasive diagnosis of nonalcoholic fatty liver disease. Ann Hepatol 2009;8:S25–33.
   PubMedGoogle Scholar
• Götte M, Echtermeyer F. Syndecan-1 as a regulator of chemokine function. Sci World J 2003;3:1327–31.
   Google Scholar
• Foley EM, Esko JD. Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins. Prog Mol Biol Transl Sci 2010;93:213–33.
   PubMedGoogle Scholar
• Deng Y, Foley EM, Gonzales JC, Gordts PL, Li Y, Esko JD. Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance. Hepatology 2012;55:277–86.
   PubMedGoogle Scholar
• Gallo R, Kim C, Kokenyesi R, Adzick NS, Bernfield M. Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J Invest Dermatol 1996;107:676–83.
   PubMed Web of Science ®Google Scholar
• Giordano RJ. Heparanase-2 and syndecan-1 in colon cancer: the ugly ducklings or the beautiful swans? Eur J Gastroenterol Hepatol 2008;20:716–18.
   PubMedGoogle Scholar
• Sanderson RD, Yang Y. Syndecan-1: a dynamic regulator of the myeloma microenvironment. Clin Exp Metastasis 2008;25:149–59.
   PubMedGoogle Scholar
• Stepp MA, Pal-Ghosh S, Tadvalkar G, Rajjoub L, Jurjus RA, Gerdes M, Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis. Mol Carcinog 2010;49:363–73.
   PubMedGoogle Scholar
• Metwaly HA, Al-Gayyar MM, Eletreby S, Ebrahim MA, El-Shishtawy MM. Relevance of serum levels of interleukin-6 and syndecan-1 in patients with hepatocellular carcinoma. Sci Pharm 2012;80:179–88.
   PubMedGoogle Scholar
• Zvibel I, Halfon P, Fishman S, Penaranda G, Leshno M, Or AB, Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C. Liver Int 2009;29:208–12.
   PubMedGoogle Scholar
• Tátrai P, Egedi K, Somorácz A, van Kuppevelt TH, Ten Dam G, Lyon M, Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer. J Histochem Cytochem 2010;58:429–41.
   PubMedGoogle Scholar
• Yilmaz Y, Eren F, Yonal O, Polat Z, Bacha M, Kurt R, Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. Dis Markers 2011;31:205–10.
   PubMed Web of Science ®Google Scholar
• Yilmaz Y, Eren F, Ayyildiz T, Colak Y, Kurt R, Senates E, Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis. Clin Chim Acta 2011;412:2296–9.
   PubMedGoogle Scholar
• Yilmaz Y, Kurt R, Eren F, Imeryuz N. Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration. Scand J Clin Lab Invest 2011;71:631–6.
   PubMed Web of Science ®Google Scholar
• Yilmaz Y, Eren F, Kurt R, Yonal O, Polat Z, Senates E, Serum galectin-3 levels in patients with nonalcoholic fatty liver disease. Clin Biochem 2011;44:955–8.
   PubMedGoogle Scholar
• ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control. Diabetes Care 2006;29:1955–62.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433–8.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313–21.
   PubMed Web of Science ®Google Scholar
• Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer 2003;98:474–83.
   PubMed Web of Science ®Google Scholar
• Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Hepatology 2006;44:1648–55.
   PubMed Web of Science ®Google Scholar
• Joensuu H, Anttonen A, Eriksson M, Mäkitaro R, Alfthan H, Kinnula V, Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res 2002;62:5210–17.
   PubMed Web of Science ®Google Scholar
• Emanuele E. Is biopsy always necessary? Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity. Hepatology 2008;48:2086–7.
   PubMed Web of Science ®Google Scholar